Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 4, 2005JNCI Journal of the National Cancer InstituteOpen Access

CYP2D6 Genotype, Antidepressant Use, and Tamoxifen Metabolism During Adjuvant Breast Cancer Treatment

View Full Paper
Ask AI
Bookmark
Share

Authors

ZDZeruesenay DestaPurdue University West LafayetteVSVered StearnsJohns Hopkins UniversityBWBrent B. WardUniversity of Michigan

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Desta et al. (2005) studied this question.

synapsesocial.com/papers/6a80ea18da9cafc35e3373bfhttps://doi.org/10.1093/jnci/dji005
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Tamoxifen in the Treatment of Breast Cancer1998 · 1,329 citations
  2. 2Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study1998 · 5,526 citations
  3. 3Phase III Evaluation of Fluoxetine for Treatment of Hot Flashes2002 · 431 citations